Clinical Trial Update: To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is ongoing to evaluate the efficacy of oral NA-921 (Bionetide) versus placebo in females with Rett syndrome; recruitment is currently o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• NA-921 (Bionetide) (NA-921)

Snippet

Sponsor: Biomed Industries, Inc. | Conditions: Rett Syndrome | Phase 3 | Status: RECRUITING